Home > Qtrly Results > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Quarterly Results Analysis [Dec2023]

NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Quarterly Results

Consolidated Dec2023
UnAudited
Sep2023
Audited
Jun2023
UnAudited
Mar2023
UnAudited
Dec2022
UnAudited
Sep2022
Audited
Jun2022
UnAudited
Mar2022
UnAudited
Revenues ₹32 Cr ₹23 Cr ₹235 Cr ₹45 Cr ₹25 Cr ₹22 Cr ₹209 Cr ₹27 Cr
Expenses ₹26 Cr ₹17 Cr ₹198 Cr ₹41 Cr ₹20 Cr ₹17 Cr ₹175 Cr ₹49 Cr
Operating Income ₹6 Cr ₹6 Cr ₹37 Cr ₹4 Cr ₹6 Cr ₹5 Cr ₹34 Cr ₹-21 Cr
Other Income ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr
Interest ₹3 Cr ₹2 Cr ₹3 Cr ₹2 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹2 Cr
Depreciation ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Profit Before Tax ₹5 Cr ₹2 Cr ₹33 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹31 Cr ₹-113 Cr
Profit After Tax ₹4 Cr ₹2 Cr ₹33 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹31 Cr ₹-116 Cr
EPS ₹2.01 ₹1.07 ₹17.47 ₹0.76 ₹0.71 ₹0.77 ₹16.18 ₹-61.22
Industry Peers & Returns1W1M1Y
NATH BIOGENES (INDIA) 0.8% -15.2% 27.9%
BOMBAY BURMAH TRADING CORPORATION 1.9% -9.3% 86.3%
KAVERI SEED COMPANY -1.5% -5.4% 22.2%
VENKYS (INDIA) -0.4% -13.5% -1.3%
BOMBAY SUPER HYBRID SEEDS NA -11.6% -31.3%
TIERRA AGROTECH 3.7% -21.5% -47.8%
INDO US BIOTECH -12.2% -26.8% 173%
MANGALAM SEEDS NA NA NA
SHREE OSWAL SEEDS AND CHEMICALS -9.4% -19.3% -35.2%

NATH BIOGENES (INDIA) Quarterly Revenues

Revenues
Q-o-Q

40.63 %

Y-o-Y

25.46 %

Quarters Revenues % Change
Dec2023 ₹32 Cr
40.63
Sep2023 ₹23 Cr
-90.41
Jun2023 ₹235 Cr
422.99
Mar2023 ₹45 Cr
77.84
Dec2022 ₹25 Cr
16.42
Sep2022 ₹22 Cr
-89.62
Jun2022 ₹209 Cr
669.33
Mar2022 ₹27 Cr -

NATH BIOGENES (INDIA) Quarterly Operating Profit

Operating Profit
Q-o-Q

2.38 %

Y-o-Y

0.55 %

Quarters Operating Profit % Change
Dec2023 ₹6 Cr
2.38
Sep2023 ₹6 Cr
-85.02
Jun2023 ₹37 Cr
835.40
Mar2023 ₹4 Cr
-29.92
Dec2022 ₹6 Cr
18.11
Sep2022 ₹5 Cr
-86.20
Jun2022 ₹34 Cr
Positive
Mar2022 ₹-21 Cr -
Operating Margins
Q-o-Q

-27.21 %

Y-o-Y

-19.86 %

Quarters Operating Margin% % Change
Dec2023 17.79%
-27.21
Sep2023 24.44%
56.27
Jun2023 15.64%
78.74
Mar2023 8.75%
-60.59
Dec2022 22.2%
1.46
Sep2022 21.88%
33.01
Jun2022 16.45%
Positive
Mar2022 -78.28% -

NATH BIOGENES (INDIA) Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

87.57 %

Y-o-Y

183.10 %

Quarters Profit After Tax % Change
Dec2023 ₹4 Cr
87.57
Sep2023 ₹2 Cr
-93.86
Jun2023 ₹33 Cr
2,207.44
Mar2023 ₹1 Cr
6.60
Dec2022 ₹1 Cr
-8.11
Sep2022 ₹1 Cr
-95.23
Jun2022 ₹31 Cr
Positive
Mar2022 ₹-116 Cr -
PAT Margins
Q-o-Q

33.37 %

Y-o-Y

125.70 %

Quarters PAT Margin(%) % Change
Dec2023 12.03 %
33.37
Sep2023 9.02 %
-36.03
Jun2023 14.1 %
340.63
Mar2023 3.2 %
-39.96
Dec2022 5.33 %
-21.15
Sep2022 6.76 %
-53.98
Jun2022 14.69 %
Positive
Mar2022 -427.51 % -

NATH BIOGENES (INDIA) Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

87.85 %

Y-o-Y

183.10 %

Quarters EPS % Change
Dec2023 ₹2.01
87.85
Sep2023 ₹1.07
-93.88
Jun2023 ₹17.47
2,198.68
Mar2023 ₹0.76
7.04
Dec2022 ₹0.71
-7.79
Sep2022 ₹0.77
-95.24
Jun2022 ₹16.18
Positive
Mar2022 ₹-61.22 -

You may also like the below Video Courses